On May 15, 2026, Galectin Therapeutics Inc. reported its financial results and operations for the quarter ending March 31, 2026. The filing includes forward-looking statements and refers to risks associated with the company's future performance.
AI Assistant
GALECTIN THERAPEUTICS INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.